Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Androidâ„¢ device!
Free
Faster access than browser!
 

Index of oncology articles and Semaxanib

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Index of oncology articles and Semaxanib

Index of oncology articles vs. Semaxanib

This is a list of terms related to oncology. Semaxanib (SU5416) is a tyrosine-kinase inhibitor drug designed by SUGEN as a cancer therapeutic.

Similarities between Index of oncology articles and Semaxanib

Index of oncology articles and Semaxanib have 6 things in common (in Unionpedia): Angiogenesis inhibitor, Clinical trial, Colorectal cancer, Sunitinib, Tyrosine-kinase inhibitor, Vascular endothelial growth factor.

Angiogenesis inhibitor

An angiogenesis inhibitor is a substance that inhibits the growth of new blood vessels (angiogenesis).

Angiogenesis inhibitor and Index of oncology articles · Angiogenesis inhibitor and Semaxanib · See more »

Clinical trial

Clinical trials are experiments or observations done in clinical research.

Clinical trial and Index of oncology articles · Clinical trial and Semaxanib · See more »

Colorectal cancer

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).

Colorectal cancer and Index of oncology articles · Colorectal cancer and Semaxanib · See more »

Sunitinib

Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006.

Index of oncology articles and Sunitinib · Semaxanib and Sunitinib · See more »

Tyrosine-kinase inhibitor

A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases.

Index of oncology articles and Tyrosine-kinase inhibitor · Semaxanib and Tyrosine-kinase inhibitor · See more »

Vascular endothelial growth factor

Vascular endothelial growth factor (VEGF), originally known as vascular permeability factor (VPF), is a signal protein produced by cells that stimulates the formation of blood vessels.

Index of oncology articles and Vascular endothelial growth factor · Semaxanib and Vascular endothelial growth factor · See more »

The list above answers the following questions

Index of oncology articles and Semaxanib Comparison

Index of oncology articles has 1711 relations, while Semaxanib has 16. As they have in common 6, the Jaccard index is 0.35% = 6 / (1711 + 16).

References

This article shows the relationship between Index of oncology articles and Semaxanib. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »